PURA PPS Potential Rated Very Bullish; Up $0.03 to $0.06 After Cannabis Extraction PR; Only 50 Million I/O; Potential to $1.00
July 19 2016 - 11:01AM
InvestorsHub NewsWire
New York, NY – July
19, 2016 – InvestorsHub NewsWire -- Wall Street Corner Report today
highlighted StockTA’s candle stick analysis indicating a
very bullish rating on the PPS potential of Puration, Inc.
(PURA).
After working quietly over the last year developing standardized
and repeatable cannabis extraction processes to produce
consistently high-quality extracts, Puration recently announced
plans to bring its extracts to market. In the past week, the
trading volume has exceeded the total number of shares traded over
the previous two years. The PPS has risen from $0.03 to $0.06
reaching a high of $0.09. With only 50 million shares I/O,
The Wall Street Corner Report believes PURA has the potential to
reach a $1.00 PPS.
Puration today announced a campaign to brand its cannabis extracts
as the leading concentrates for infusion into recognized food and
beverage consumer products:
Puration Announces Campaign to Brand
Cannabis Extract in Food and Beverage Consumer Products Market Led
by Beverage Industry Veteran
The Company was also featured today in a
Cannabis Industry article also mentioning PharmaCyte Biotech, Inc. (PMCB), GrowLife, Inc. (PHOT), Hemp, Inc. (HEMP) & Medical Marijuana,
Inc. (MJNA):
The Wall Street Corner Report considers
PURA comparable to an earlier version of
GW
Pharmaceuticals (GWPH) in that both are
developing commercial applications of cannabis extracts.
Wall Street Corner Report anticipates PURA to experience an
‘accumulation phase’ with the shareholder base expanding and
diversifying. As the Company’s news becomes more disseminated
throughout the market, Wall Street Corner Report
anticipates a rapid PPS increase to as high as
$1.00.
GWPH has a market cap of $2B - approximately
33 times revenue. The majority of revenue is non-cash
consideration while the company is still largely in a research
phase. If PURA were to achieve a
valuation at only 15 times its forecasted $3 million revenue, the
PPS would be $0.90.
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and as such, may involve risks and
uncertainties. These forward looking statements relate to, amongst
other things, current expectation of the business environment in
which the company operates, potential future performance,
projections of future performance and the perceived opportunities
in the market. The company's actual performance, results and
achievements may differ materially from the expressed or implied in
such forward-looking statements as a result of a wide range of
factors.
Jack Taylor
info@wallstreetcornerreport.com
Growlife (CE) (USOTC:PHOT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Growlife (CE) (USOTC:PHOT)
Historical Stock Chart
From Apr 2023 to Apr 2024